Recent approaches for reducing hemolytic activity of chemotherapeutic agents

Maier-Redelsperger, 2010, Strong association between a new marker of hemolysis and glomerulopathy in sickle cell anemia, Blood Cells Mol. Dis., 45, 289, 10.1016/j.bcmd.2010.08.001 Sirdah, 2012, Hemolysis and Mediterranean G6PD mutation (c.563 C>T) and c.1311 C>T polymorphism among Palestinians at Gaza Strip, Blood Cells Mol. Dis., 48, 203, 10.1016/j.bcmd.2012.01.007 Pierce, 2011, Pathology consultation on drug-induced hemolytic anemia, Am. J. Clin. Pathol., 136, 7, 10.1309/AJCPBVLJZH6W6RQM Davis, 1997, Biomedical applications of nanotechnology—implications for drug targeting and gene therapy, Trends Biotechnol., 15, 217, 10.1016/S0167-7799(97)01036-6 M.N. Ton, C. Chang, Y.A. Carpentier, R.J. Deckelbaum, In vivo and in vitro properties of an intravenous lipid emulsion containing only medium chain and fish oil triglycerides, Clin. Nutr. 24 492–501. Moghimi, 2001, Long-circulating and target-specific nanoparticles: theory to practice, Pharmacol. Rev., 53, 283 Gref, 1994, Biodegradable long-circulating polymeric nanospheres, Science (New York, N.Y.), 263, 1600, 10.1126/science.8128245 Sellami, 2013, Newly synthesized dopamine ester derivatives and assessment of their antioxidant, antimicrobial and hemolytic activities, Process Biochem., 48, 1481, 10.1016/j.procbio.2013.07.022 Pachioni, 2013, Alkylphospholipids — a promising class of chemotherapeutic agents with a broad pharmacological spectrum, J. Pharm. Pharm. Sci., 16, 742, 10.18433/J3CW23 Jumaa, 2000, Lipid emulsions as a novel system to reduce the hemolytic activity of lytic agents: mechanism of the protective effect, Eur. J. Pharm. Sci., 9, 285, 10.1016/S0928-0987(99)00071-8 Cruz Silva, 2001, Hydroxytamoxifen interaction with human erythrocyte membrane and induction of permeabilization and subsequent hemolysis, Toxicol. in Vitro, 15, 615, 10.1016/S0887-2333(01)00079-0 Gauthier, 2009, Haemolytic activity, cytotoxicity and membrane cell permeabilization of semi-synthetic and natural lupane- and oleanane-type saponins, Bioorg. Med. Chem., 17, 2002, 10.1016/j.bmc.2009.01.022 Larson, 2012, Polymeric conjugates for drug delivery, Chem. Mater., 24, 840, 10.1021/cm2031569 Pasut, 2007, Polymer–drug conjugation, recent achievements and general strategies, Prog. Polym. Sci., 32, 933, 10.1016/j.progpolymsci.2007.05.008 Ajazuddin, 2013, Synthesis, characterization and in vitro studies of pegylated melphalan conjugates, Drug Dev. Ind. Pharm., 39, 1053, 10.3109/03639045.2012.702346 Alexander, 2015, A comparative study of chitosan and poloxamer based thermosensitive hydrogel for the delivery of PEGylated melphalan conjugates, Drug Dev. Ind. Pharm., 1, 10.3109/03639045.2015.1011167 Kumar, 2011, Nonionic surfactant vesicular systems for effective drug delivery—an overview, Acta Pharm. Sin. B, 1, 208, 10.1016/j.apsb.2011.09.002 Deng, 2012, Biodegradable polymeric micelles for targeted and controlled anticancer drug delivery: promises, progress and prospects, Nano Today, 7, 467, 10.1016/j.nantod.2012.08.005 Falamarzian, 2010, Optimization of the hydrophobic domain in poly(ethylene oxide)-poly(ɛ-caprolactone) based nano-carriers for the solubilization and delivery of Amphotericin B, Colloids Surf. B Biointerfaces, 81, 313, 10.1016/j.colsurfb.2010.07.025 Lavasanifar, 2001, Micelles self-assembled from poly(ethylene oxide)-block-poly(N-hexyl stearate l-aspartamide) by a solvent evaporation method: effect on the solubilization and haemolytic activity of amphotericin B, J. Control. Release, 77, 155, 10.1016/S0168-3659(01)00477-1 Vandermeulen, 2006, Encapsulation of amphotericin B in poly(ethylene glycol)-block-poly(ɛ-caprolactone-co-trimethylenecarbonate) polymeric micelles, Int. J. Pharm., 309, 234, 10.1016/j.ijpharm.2005.11.031 Li, 2009, Self-assembled polymeric micellar nanoparticles as nanocarriers for poorly soluble anticancer drug ethaselen, Nanoscale Res. Lett., 4, 1502, 10.1007/s11671-009-9427-2 Shuai, 2004, Micellar carriers based on block copolymers of poly(epsilon-caprolactone) and poly(ethylene glycol) for doxorubicin delivery, J. Control. Release, 98, 415, 10.1016/j.jconrel.2004.06.003 Park, 2005, Biodegradable polymers for microencapsulation of drugs, Molecules, 10, 146, 10.3390/10010146 Serrano, 2013, Hemolytic and pharmacokinetic studies of liposomal and particulate amphotericin B formulations, Int. J. Pharm., 447, 38, 10.1016/j.ijpharm.2013.02.038 Doh, 2013, A novel lipid nanoemulsion system for improved permeation of granisetron, Colloids Surf. B Biointerfaces, 101, 475, 10.1016/j.colsurfb.2012.07.019 Lovelyn, 2011, Current state of nanoemulsions in drug delivery, J. Biomater. Nanobiotechnol., 2, 626, 10.4236/jbnb.2011.225075 Jing, 2013, A novel polyethylene glycol mediated lipid nanoemulsion as drug delivery carrier for paclitaxel, Nanomed. Nanotechnol. Biol. Med., 10, 371, 10.1016/j.nano.2013.07.018 Alkhatib, 2013, Cytotoxicity of gemcitabine-loaded-microemulsions in breast and colon cancer cells, Trop. J. Pharm. Res., 13, 217, 10.4314/tjpr.v13i2.8 Jumaa, 2002, A new lipid emulsion formulation with high antimicrobial efficacy using chitosan, Eur. J. Pharm. Biopharm., 53, 115, 10.1016/S0939-6411(01)00191-6 Nornoo, 2008, Cremophor-free intravenous microemulsions for paclitaxel: I: formulation, cytotoxicity and hemolysis, Int. J. Pharm., 349, 108, 10.1016/j.ijpharm.2007.07.042 Wang, 2011, A novel paclitaxel microemulsion containing a reduced amount of Cremophor EL: pharmacokinetics, biodistribution, and in vivo antitumor efficacy and safety, J. Biomed. Biotechnol., 2011, 854872, 10.1155/2011/854872 Jeswani, 2013, Topical delivery of Curcuma longa extract loaded nanosized ethosomes to combat facial wrinkles, Pharm. Drug Deliv. Res., 3, 1 Brewer, 2011, Natural antioxidants: sources, compounds, mechanisms of action, and potential applications, Compr. Rev. Food Sci. Food Saf., 10, 221, 10.1111/j.1541-4337.2011.00156.x Ramadass, 2012, Attenuation of mitochondrial oxidative stress by morin during chemical carcinogen-mediated mammary carcinogenesis, Biomed. Prev. Nutr., 2, 9, 10.1016/j.bionut.2011.11.004 Takano, 2004, Protective effect of (+)-catechin against 5-fluorouracil-induced myelosuppression in mice, Toxicology, 201, 133, 10.1016/j.tox.2004.04.009 Shak, 2013, Novel role for the Streptococcus pneumoniae toxin pneumolysin in the assembly of biofilms, mBio, 4, 10.1128/mBio.00655-13 Rabinkov, 1998, The mode of action of allicin: trapping of radicals and interaction with thiol containing proteins, Biochim. Biophys. Acta Gen. Subj., 1379, 233, 10.1016/S0304-4165(97)00104-9 Arzanlou, 2011, Allicin from garlic neutralizes the hemolytic activity of intra- and extra-cellular pneumolysin O in vitro, Toxicon, 57, 540, 10.1016/j.toxicon.2010.12.009 Yong, 2013, Clinacanthus nutans extracts are antioxidant with antiproliferative effect on cultured human cancer cell lines, Evid. Based Complement. Alternat. Med., 8, 1, 10.1155/2013/462751 Marouf, 2011, Free radical scavenging activity of silibinin in nitrite-induced hemoglobin oxidation and membrane fragility models, Saudi Pharm. J., 19, 177, 10.1016/j.jsps.2011.03.006 Shabbir, 2013, Assessment of phytochemicals, antioxidant, anti-lipid peroxidation and anti-hemolytic activity of extract and various fractions of Maytenus royleanus leaves, BMC Complement. Alternat. Med., 13, 1, 10.1186/1472-6882-13-143 Thephinlap, 2013, Anti-oxidant properties and anti-hemolytic activity of Psidium guajava, Pandanous odorus and Rhinacanthus nasutus, J. Med. Plants Res., 7, 2001, 10.5897/JMPR12.800 Tamaki, 2012, Fatty acyl-gramicidin S derivatives with both high antibiotic activity and low hemolytic activity, Bioorg. Med. Chem. Lett., 22, 106, 10.1016/j.bmcl.2011.11.062 Arias, 2010, Red blood cell permeabilization by hypotonic treatments, saponin, and anticancer avicins, Biochim. Biophys. Acta Biomembr., 1798, 1189, 10.1016/j.bbamem.2010.03.018 Cruz Silva, 2000, Hemolysis of human erythrocytes induced by tamoxifen is related to disruption of membrane structure, Biochim. Biophys. Acta, 1464, 49, 10.1016/S0005-2736(99)00237-0 Hurteau, 2010, Gynecol. Oncol., 119, 444, 10.1016/j.ygyno.2010.08.002 de Oliveira, 2011, Biological evaluation of twenty-eight ferrocenyl tetrasubstituted olefins: cancer cell growth inhibition, ROS production and hemolytic activity, Eur. J. Med. Chem., 46, 3778, 10.1016/j.ejmech.2011.05.043 Kim, 2009, Synthesis of antibacterial pseudopeptides with less hemolytic activity from a cytotoxic peptide and their pH-dependent activity, Bioorg. Med. Chem. Lett., 19, 5627, 10.1016/j.bmcl.2009.08.031 Abdolhosseini, 2012, Lysine substitutions convert a bacterial-agglutinating peptide into a bactericidal peptide that retains anti-lipopolysaccharide activity and low hemolytic activity, Peptides, 35, 231, 10.1016/j.peptides.2012.03.017 Findlay, 2012, Neomycin-phenolic conjugates: polycationic amphiphiles with broad-spectrum antibacterial activity, low hemolytic activity and weak serum protein binding, Bioorg. Med. Chem. Lett., 22, 1499, 10.1016/j.bmcl.2012.01.025 Tamaki, 2011, Novel gratisin derivatives with high antimicrobial activity and low hemolytic activity, Bioorg. Med. Chem. Lett., 21, 440, 10.1016/j.bmcl.2010.10.122 Tamaki, 2009, Syntheses of low-hemolytic antimicrobial gratisin peptides, Bioorg. Med. Chem. Lett., 19, 2856, 10.1016/j.bmcl.2009.03.133 Li, 2007, Synthesis, cytotoxicity, and hemolytic activity of 6′-O-substituted dioscin derivatives, Carbohydr. Res., 342, 2705, 10.1016/j.carres.2007.09.004 van Blitterswijk, 2013, Anticancer mechanisms and clinical application of alkylphospholipids, Biochim. Biophys. Acta, 1831, 663, 10.1016/j.bbalip.2012.10.008 Jing, 2014, A novel polyethylene glycol mediated lipid nanoemulsion as drug delivery carrier for paclitaxel, Nanomed. Nanotechnol. Biol. Med., 10, 371, 10.1016/j.nano.2013.07.018 Serrano, 2013, Hemolytic and pharmacokinetic studies of liposomal and particulate amphotericin B formulations, Int. J. Pharm., 447, 38, 10.1016/j.ijpharm.2013.02.038